1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ENTRADA THERAPEUTICS INC
Entrada Therapeutics Inc
XNAS: TRDA
11.98 0.10 (0.84%)
207.1K
XNAS Volume

XNAS 19 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Entrada Therapeutics Inc - TRDA - stock price prediction, stock price target, analyst ratings from 7 analysts

Entrada Therapeutics Inc has a share price target of US$ 20, revenue growth forecast of -2.0%, and profit growth estimate of -24.8% for FY26, based on top 7 analyst calls.